Lensar (LNSR) Gross Profit Growth (1y) (2020 - 2026)
Lensar (LNSR) Gross Profit Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 15.74% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -1.74% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 27.39% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 8.72% |
| 10 | Lensar | 70.41 Mn | 70.70 Mn | 6.38 Mn | -10.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.43% |
| Dec 31, 2025 | 33.43% |
| Sep 30, 2025 | -28.57% |
| Jun 30, 2025 | 10.66% |
| Mar 31, 2025 | 253.75% |
| Dec 31, 2024 | 46.66% |
| Sep 30, 2024 | 28.48% |
| Jun 30, 2024 | -28.10% |
| Mar 31, 2024 | -207.27% |
| Dec 31, 2023 | -45.31% |
| Sep 30, 2023 | 101.78% |
| Jun 30, 2023 | 94.45% |
| Mar 31, 2023 | 31.19% |
| Dec 31, 2022 | -29.28% |
| Sep 30, 2022 | -37.24% |
| Jun 30, 2022 | 4.79% |
| Mar 31, 2022 | 18.33% |
| Dec 31, 2021 | 27.59% |
| Sep 30, 2021 | -1.16% |
| Jun 30, 2021 | 70.50% |